Smart investors can spot trends. They can predict what will happen next and anyone who is paying attention knows that the marijuana industry is booming, expanding, and thriving. In fact, conservative estimates predict that the industry is expected to be worth 21 billion dollars by the end of 2020. Welcome to the Green Rush, where anyone with a bit of foresight and capital can get in on this rapidly growing industry. It should be noted, that not all investments are equal in merit. It is then important for investors to recognize innovative ideas and to capitalize on emerging trends.
Enter: MyDx, Inc. (OTCQB:MYDX) a science and technology company based in San Diego, California, that has created MyDx, the world’s first portable, handheld, chemical analyzer for consumers. Our first sensor, CannaDx, is capable of analyzing cannabis samples for potency and medical viability (cannabinoids, such as THC, and terpenes) and our other sensors, AquaDx, OrganaDx, and AeroDx, are currently being developed by our R&D Team.
Our vision is simple: empower users to Trust and Verify™ what they put into their minds and bodies. Whether that is food, water, air, or cannabis – we believe that everyone should have the right to know exactly what they are consuming. MyDx utilizes electronic nose nanotechnology – allowing our various sensors to detect certain compounds of interest. This information is then relayed to the user’s smart phone using the MyDx App where it is interpreted and explained to the user by our company mascot, MollieCule.
This publicly traded science and technology company is the perfect opportunity for investors looking to purchase marijuana stocks. MyDx is a safer bet than directly investing in the cannabis industry for two reasons: MyDx does not manufacture or handle any marijuana (which is still illegal on the federal level) and because this company isn’t limited to cannabis applications. Our air, water, and food sensors will ensure access to a diverse, robust, and broad market.
Potential cannabis stock investors who believe in the medicinal benefits of cannabis should view MyDx as an ideal investment. In our aim to legitimize cannabis as a medicine, we are working to compile a crowd-sourced and HIPPA-protected database where users can predict how a cannabis sample will make them feel or what symptoms it will relieve. We believe that this database will serve as the framework for future clinical trials and cannabis research. We are also seeking partnerships with institutions currently evaluating the medicinal qualities of cannabis.
All of this puts MyDx at the forefront of cannabis testing and use – while at the same time not limiting its potential to one market. This makes MyDx an excellent opportunity for investors who have been sitting on the sidelines because they are worried about the perceived volatility and risk associated with the cannabis industry. Health conscious consumers will undoubtedly look to purchase personal analyzers and naturally a market will arise to meet these needs. As of today, MyDx is poised to lead and dominate the personal analyzer market, making it an ideal marijuana stock for investors looking to capitalize on the Green Rush. The lack of regulation among cannabis testing labs and the demand for user operated personal cannabis testing kits ensures that MyDx will have vitality in the cannabis industry and beyond.
This video will explain just how simple and easy it is to use MyDx to test cannabis samples and the MyDx White Paper will explain all of the technical nuance utilized by this innovative device. If you have any questions or if you would like to invest please feel free to contact us.
Enter the “Green Rush” by Buying MyDx Stock
The marijuana industry in the U.S. is booming. Several states, including California and Colorado, recently legalized recreational use of cannabis. By the end of 2020, the marijuana industry in the country is estimated to be worth 21 billion dollars. That’s only a conservative estimate. There are no reasons why investors should not invest in marijuana stock right now.
Welcomes to the “Green Rush”
There are different types of marijuana stock available for interested parties. For example, stocks for medical and recreational marijuana are different from a company that mainly sells pot for recreational uses. Cannabis research stock has remained steady in recent times after Colorado legalized pot. Now, for companies located in states where recreational marijuana use is legal, the stocks will go up. The same is true for recreational marijuana companies.
The best way to go about investing in cannabis stock is to put money where the innovation is. The raw marijuana industry has spurred the growth of a support industry where a number of tech-related companies provide services to marijuana users. MyDx is one of these companies. The IT nature of these companies, combined with the rising demand for legal marijuana, make companies like MyDx perfect for long-term investors.
What is MyDx?
MyDx, Inc. (OTCQB:MYDX) is mainly a science and tech company headquartered in San Diego, California. The company is noted for creating the world’s first portable and handheld chemical analyzer for marijuana users. The company’s products include CannaDx, a popular sensor that can analyze the levels of terpenes and cannabinoids is strains of marijuana.
The company also sells AeroDx, and indoor air quality sensor, and AquaDx, a water purity sensor. OrganaDX, which can test food and cannabis for levels of pesticide and heavy metals, is the latest device invented by the company. The company is heavily focused on tech solutions to consumer demand driven by marijuana.
Why Invest in MyDx?
Investors generally consider recreational cannabis stock investments to be high risk compared to pharmaceutical marijuana investments stocks. MyDx stock does not fall into either category easily. The company, by nature, is a tech company, not a pot company. Also, MyDx devices can be used by both medical and recreational marijuana users.
Therefore, MyDx stock is not necessarily subject to the volatility and risk associated with recreational marijuana. As long as medical marijuana use is legal, the devices will have demand. If you are looking for long-term cannabis stocks to buy, MyDx stock offers a relatively low-risk stocks for potentially very high returns in the near future.
The best strategy is to buy cannabis stock and hold it for the long term. While some may see upsides in trading cannabis stocks in quick successions, those who hold out for federal legalization may get the best returns. According to one trader, investors who hold onto marijuana stock for three to five years may see almost returns that could be as much as 100 times the original investment.
